Zhao Y, Hu Z, Bathena SP, Keidel S, et al. Model-Informed Clinical Pharmacology Profile of a Novel Fixed-Dose Combination of Nivolumab and Relatlimab in Adult and Adolescent Patients with Solid Tumors. Clin Cancer Res 2024;30:3050-3058.
PMID: 38295151